CDC confirms 12 sick in ongoing E coli outbreak linked to frozen blueberries
A novel human papillomavirus (HPV) vaccine, manufactured using Escherichia coli, demonstrates strong protection against cancer-causing HPV strains in women. This finding, detailed in a recent study published in The Lancet Infectious Diseases, holds significant promise for expanding global access to HPV immunization, particularly in low- and middle-income countries, due to its lower production cost compared … Read more